Cargando…

ANGI-01 ALTERATION IN IMMUNE REGULATORY CELLS BEFORE AND AFTER TREATMENT BY STUPP REGIMEN WITH OR WITHOUT BEVACIZUMAB FOR GLIOBLASTOMA

BACKGROUND: In our previous study, bevacizumab (Bev), a humanized anti- vascular endothelial growth factor monoclonal antibody, downregulated the expression of programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) immune checkpoint molecules, suppressed the infiltration of immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Toshihide, Tamura, Ryota, Yamamoto, Yohei, Morimoto, Yukina, Teshigawara, Akihiko, Tochigi, Satoru, Hasegawa, Yuzuru, Takei, Jun, Akasaki, Yasuharu, Sasaki, Hikaru, Murayama, Yuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213323/ http://dx.doi.org/10.1093/noajnl/vdz039.019

Ejemplares similares

ANGI-1 Impact of neoadjuvant bevacizumab on transcriptional factor for stemness, macrophage polarization, and oxygenation of tumor microenvironment in glioblastoma
por: Tanaka, Toshihide, et al.
Publicado: (2021)

CS-01 Rapid Recurrence and Anaplastic Transformation of a Pilocytic Astrocytoma in an Elderly Patient
por: Tanaka, Toshihide, et al.
Publicado: (2020)

ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY
por: Suzuki, Tomoya, et al.
Publicado: (2022)

“Paradoxical” findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab
por: Yamamoto, Yohei, et al.
Publicado: (2017)

Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2018)

Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2020)

Chronic Encapsulated Expanding Thalamic Hematoma Associated with Obstructive Hydrocephalus following Radiosurgery for a Cerebral Arteriovenous Malformation: A Case Report and Literature Review
por: Takei, Jun, et al.
Publicado: (2016)

Alteration of FOXM1 expression and macrophage polarization in refractory meningiomas during long-term follow-up
por: Takei, Jun, et al.
Publicado: (2021)

COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma
por: Yamamoto, Yohei, et al.
Publicado: (2020)

Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas
por: Takei, Jun, et al.
Publicado: (2022)

IMT-01 THERAPEUTIC EFFECT AGAINST LOWER GRADE GLIOMA INDUCED BY DENDRITIC CELL BASED IMMUNOTHERAPY
por: Akasaki, Yasuharu, et al.
Publicado: (2019)

IMT-1 PROS AND CONS OF SURGICAL INTERVENTION FOR DIFFUSE MIDLINE GLIOMA AIMED AT DENDRITIC CELL IMMUNOTHERAPY
por: Akasaki, Yasuharu, et al.
Publicado: (2022)

COT-11 Administration of Bevacizumab for patients who failed to complete Stupp regimen after glioblastoma surgery
por: Kon, Takashi, et al.
Publicado: (2020)

Angi Vera
Publicado: (1995)

IMT-1 A translational research for practical use of dendritic cell-based immunotherapy against malignant glioma
por: Akasaki, Yasuharu, et al.
Publicado: (2021)

Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade
por: Lakomy, Radek, et al.
Publicado: (2020)

ANGI-2 Identification and functions of CD44 as a predictor for bevacizumab-resistant glioblastoma to optimally treat the tumor with bevacizumab
por: Inoue, Akihiro, et al.
Publicado: (2021)

Histopathological investigation of glioblastomas resected under bevacizumab treatment
por: Tamura, Ryota, et al.
Publicado: (2016)

ANGI-05 PATHOGENESIS OF RESISTANCE (MIMICRY AND CO-OPTION) TO ANTI-ANGIOGENIC TREATMENT FOR GLIOBLASTOMA
por: Takano, Shingo, et al.
Publicado: (2019)

A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma
por: Tamura, Ryota, et al.
Publicado: (2020)

MET-4 ANALYSIS OF METASTATIC BRAIN TUMORS DISCOVERED AT THE SAME TIME AS THE PRIMARY LESION
por: Yamamoto, Yohei, et al.
Publicado: (2022)

Delayed Tentorial Subdural Hematoma Caused by Traumatic Posterior Cerebral Artery Aneurysm: A Case Report and Literature Review
por: Fuga, Michiyasu, et al.
Publicado: (2021)

Successful Endovascular Trapping for Symptomatic Thrombosed Giant Unruptured Aneurysms of the V1 and V2 Segments of the Vertebral Artery: Case Report and Literature Review
por: FUGA, Michiyasu, et al.
Publicado: (2021)

Horizontal stenting via retrograde route for recurrent ruptured posterior communicating artery aneurysm after clipping: A case report and literature review
por: Fuga, Michiyasu, et al.
Publicado: (2022)

Local thrombolytics via balloon-assisted intra-arterial infusion as rescue therapy for thromboembolism during endovascular coil embolisation
por: Fuga, Michiyasu, et al.
Publicado: (2023)

Refractory De Novo Multiple Cerebral Aneurysms After Radiotherapy and Multistaged “Open” Surgical Treatment for Low-Grade Glioma During Long-Term Follow-Up: A Case Report and Review of the Literature
por: Maruyama, Fumiaki, et al.
Publicado: (2019)

Concomitant Intracranial and Lumbar Chronic Subdural Hematoma Treated by Fluoroscopic Guided Lumbar Puncture: A Case Report and Literature Review
por: ICHINOSE, Daisuke, et al.
Publicado: (2018)

Spinal Extradural Arteriovenous Fistula with Cowden Syndrome: A Case Report and Literature Review Regarding Pathogenesis and Therapeutic Strategy
por: Takei, Jun, et al.
Publicado: (2018)

Predicting difficult transradial approach guiding into left internal carotid artery on unruptured intracranial aneurysms
por: Fuga, Michiyasu, et al.
Publicado: (2023)

Characteristics of Unruptured Intracranial Aneurysms with Delayed Rupture Following Coil Embolization: Case Series and Review of the Literature
por: Tachi, Rintaro, et al.
Publicado: (2022)

High-resolution three-dimensional ANGIE T1 mapping of the whole heart
por: Mehta, Bhairav B, et al.
Publicado: (2015)

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
por: Warren, Kwanza T., et al.
Publicado: (2019)

Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol
por: Adegboyega, Gideon, et al.
Publicado: (2021)

The Anorexia Nervosa: Genetics Initiative (ANGI): Australia and New Zealand join forces
por: Kennedy, Martin, et al.
Publicado: (2015)

Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp’s Trial: More Controversies than Standards?
por: Kazda, Tomas, et al.
Publicado: (2018)

Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol
por: Topkan, Erkan, et al.
Publicado: (2020)

Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
por: Gurrieri, Lorena, et al.
Publicado: (2023)

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
por: Takei, Jun, et al.
Publicado: (2023)

TIPS-11 EFFICACY AND SAFETY OF STUPP REGIMEN WITH OR WITHOUT ANLOTINIB FOR NEWLY DIAGNOSED GLIOBLASTOMA: INTERIM RESULTS OF A MULTICENTER, DOUBLEBLIND, RANDOMIZED PHASE II TRIAL
por: Chen, Yuanyuan, et al.
Publicado: (2023)

Accelerated and navigator-gated look-locker imaging for cardiac T1 Estimation (ANGIE) with reduced motion artifact
por: Mehta, Bhairav B, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6oehel4np5v6455hl5s77ejeb7